D-PLEX100 Administration into the Surgical Site Led to Statistically Significant Reduction in Infections Compared to Standard of Care Alone Company Intends to Hold End of Phase 2 Meeting with FDA and Subsequently Submit an IND to Conduct a Phase 3 Clinical Trial in...
Amphivena Therapeutics, Inc., a private clinical stage immuno-oncology company developing T cell engager therapeutics for cancer, today announced dosing of the first patient in a Phase 1 clinical trial in solid tumors evaluating AMV564, a CD33/CD3 T cell engager that...
– Investigational compound BI ENaC inhibitor delivered twice daily via the Respimat®, a handheld inhaler RIDGEFIELD, Conn., Oct. 16, 2019 /PRNewswire/ — Boehringer Ingelheim today announced the first patient enrolled in its Phase II clinical trial...
Clinical trials not only facilitate new drug development, but they can provide care to patients who desperately need more options, such as those with cancer. While trials may be listed online in readily accessible databases, such as those listed...
A new clinical trial will test whether cannabidiol (CBD) products are safe to use as a treatment for Parkinson disease (PD)-related psychosis, MD Magazine reported. According to the article, a team of researchers will be conducting a phase 2 clinical trial testing the...
First participants enrolled in pivotal Phase 3 clinical trial of NanoFlu Top-line clinical data expected in the first quarter of 2020 Phase 3 results expected to support a future BLA and licensure of NanoFlu using the FDA’s accelerated approval pathway GAITHERSBURG,...
Email
Text